GENE ONLINE|News &
Opinion
Blog

Acceleron
M&A Best of 2021
GeneOnline’s Top 10 M&As of 2021
2022-01-11
M&A Cardiovascular Disease
Merck Acquires Acceleron for $11.5 Billion, Gaining Access to a Phase 3 Cardiovascular Asset
2021-09-30
Trials & Approvals Beta-thalassemia
Celgene, Acceleron’s novel anemia drug gets FDA green light for rare blood disorder
2019-11-11
LATEST
From Sweet to Risky: The Alarming Findings on Sucralose’s Genotoxicity
2023-06-07
GHG Emissions as a ESG Metric
2023-06-07
NSTC Joins Forces with Taiwan Biomedical Start-ups to Rise to the World Stage, Showcasing Innovations at US BIO’s Demo Day
2023-06-07
Krystal Biotech’s First Topical Gene Therapy Approved by FDA
2023-06-06
The Emergence of General AI for Medicine: Medical Applications of ChatGPT
2023-06-06
Strengthening Genetic Screening Platform in APAC for Lung Cancer Precision Medicine: An Interview with Dr. Koichi Goto
2023-06-05
2023 International Healthcare Week: Showcasing Emerging Competencies of Hong Kong’s Biomedical Industry
2023-06-05
READ MORE
EVENT
2023-06-05
Redefining Early Stage Investments (RESI) 2023 conference series – RESI Boston
Boston, USA
2023-06-05
BIO International Convention (BIO 2023)
Boston,USA
2023-07-26
BIO Asia-Taiwan 2023
Taipei, Taiwan
2023-09-06
2023 Bio Asia Pacific
Bangkok, Thailand
2023-11-16
3rd INTERNATIONAL CONFERENCE ON NUTRITION AND HEALTHCARE
Dubai, UAE
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top